Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Congrats to the long. +450%
No matter where you go, there will always be loans and dilution in the public markets. If a company operates genuinely in my view, I'm fine with it. I may not commit to holding the stock indefinitely, but I won't criticize people or be irrationally stupid to blame others for my actions. Everyone has their history and, their behavior and I respect that.
Regarding BDPT, I perceive it as a genuine company with marketable products, lacking only the right marketing strategy to boost sales. BDPT's market cap of 543k with an extremely low outstanding share count is laughable to me. It's rare to find a sub-penny stock with only 776M outstanding shares that hasn't diluted since July.
Looking at the next trench with the lowest offer at .001, even if the outstanding shares remain at one billion, the market value would be just 1 million at .001. Compare this to other stocks like AAGH with a .011 price and 21 billion outstanding shares, ASTA at .0029 with 6 billion shares, or SPZI at .0009 with 5.4 billion outstanding shares, which I saw a stock run of +375% today. There are numerous examples. Considering this, BDPT appears undervalued to me. I won't hesitate to purchase at this attractive price. No pumping is needed, it's as straightforward as that; simple buy/sell make what you want out of it.
Well input!
Examine the stock price movement. Analyze the market activity, and you'll notice a significant disparity between the number of buyers and the minimal selling reflected on the tape. Despite dilution and the influence of short sellers, a substantial rebound seems inevitable. The timing of this rebound is uncertain—it could happen within a day or stretch over a week. Imho.
Thank you bud. I'm doing great. This is a Chinese POS scam all the way. Roll the dice all gambles.
Manipulate at its best. Massive buy, all green bars and they lower the price.
Awesome! Class A Tiffin motorhomes Paeton. My RV Park is located in Magnolia, TX. It's Magnolia Hills RV Park.
$BETS The dip was a gift yesterday.
Not the same this time is a private offer.
The offer is .065. Loved the cheapies.
I bought my second order PluriPain® I loved it.
The securities sold in a private offering are restricted, meaning that they cannot be resold without either an effective registration statement being filed, or a separate exemption for the resale.
Super tiny float here. The last time they put out news stock moved over 2000% in one day.
Great to see you here bro.
Took 6 million shares from the stupid Dumbnut!
Yesterday, I confirmed that the TA share structure remains unchanged. Currently, I'm occupied with developing an RV park on my property with 42 units, which means I have limited time to focus on the market. However, this doesn't imply that I've completely withdrawn from the market or lost interest in BioAdaptives Inc.
Selling at this price level would be an action taken by someone desperate for money, and it's not a rational move for those in their right mind. I've consistently mentioned my exclusive interest in the spin-off, and if the company fails to execute its business plan effectively, life moves on. Despite this, I still hold a significant number of shares. I've been supporting this stock since it was at .0004, repeatedly advising people to take profits on the way up. Trading should be about making money; if people aren't making money, perhaps trading isn't suitable for them.
Make no mistake this stock isn't dead; it has an exceptionally low outstanding share count for a triple 0 stock. There will be moments when it will shine again.
As I've emphasized from the start, the success of DD notwithstanding, effective management execution is paramount. Finalizing the spin-off is a critical step. They are dedicating excessive time to new product development without addressing long-term financial working capital issues is concerning. The spin-off presents a solution, but it appears that there is a lack of urgency in addressing this crucial matter.
AAPJ SECURITY DETAILS: SS UPDATE UNCHANGED. NO DILUTION.
Share Structure
Market Cap Market Cap
1,601,890
11/24/2023
Authorized Shares
3,000,000,000
11/24/2023
Outstanding Shares
1,779,878,081
11/24/2023
Restricted
1,160,357,945
11/24/2023
Unrestricted
619,520,136
11/24/2023
Held at DTC
572,647,400
11/24/2023
Nice volume here today!
I added a few more yesterday and looking forward to the merger.
LOL:))
People are here. They may not be actively posting, which doesn't necessarily mean they have sold their stock or moved on.
I say I completely agree with you. lol:))
“I completely concur with your viewpoint”
Indeed, I'm optimistic that the market is taking a positive turn.
I completely concur with your viewpoint. Let's be patient and savor the moments.
By the way, I don’t read their posts.
Why?
I know that they are not smart at all and I know what they are going to say/write.
Deja -Vue?
When I see see their names, no need to read lol.
Why to waste my energy and time to read them.
I am enjoying my Friday happy hours drinks.
Please, tell them good to see them here since they have nothing else to do every day 24/7.. We understand they need a shelter…
You were right about the NIO it dropped to $7's
I've discussed this matter with you extensively. If you're still uncertain, please refer to the link below where I've provided my previous explanation.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173104698
As of the present date, LiveStock is still on the books of BioAdaptives, Inc. because the Livestock Impact Division was initially a wholly-owned subsidiary. Don't distort information to mislead readers when you can't fully grasp the financial details in the filings.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173107353
Let's clarify something upfront: The BDPT spin-off has not yet taken place. The false information being circulated here claims the spin-off has already occurred, which is both inaccurate and misleading. It appears that some individuals are still unaware of the spin-off process, and I've provided a comprehensive explanation in the link below.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173117267
Let's put an end to spreading false information and baseless rumors. When I endorse someone's statement, those are their words, not mine.
DSS operates nine business divisions they spun off two divisions.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173139751
Etrade allows trading I have no problem buying the stock.
I prioritize thorough due diligence to distinguish myself from those merely pumping the stock based on hype and speculation.
In alignment with your statement "get real news after the quiet period ends," I find myself in agreement with your perspective.
I want to see them finalize and announce the details of the spin-off news. This announcement can provide clarity and information for investors and stakeholders.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173139751
Cut the endless nagging off. I see +30% green.
Nice bid supporting. 0012 up can we see .0015 today?
Good to see you here. I bought a few shares today.
How is it possible for a company that didn't generate ANY REVENUE in 2022 and recorded a loss of $7.26 million to proceed with a spin-off and plan to sell 2 million shares for $3 to $5 in its initial public offering? How is it possible for a company trading at just 14 cents to spin off a subsidiary and sell 2 million shares for $3 to $5 each? Surprisingly, this scenario is happening right now, and it's not uncommon in the stock market.
Does this scenario apply similarly to the $BDPT case? Let's consider all the facts; please take a closer look at the link below:
Published: Nov. 1, 2023.
The company didn't generate any revenue in 2022 and recorded a loss of $7.26 million. DSS distributed shares of Impact Biomedical to its shareholders in July as part of the spinoff.
https://www.marketwatch.com/story/impact-biomedical-to-sell-2m-shares-for-3-to-5-in-ipo-6684cb13
$BDPT +50% YES, TIME TO RE-ENTER, DOWN FROM .005
$BDPT +50% YES, TIME TO RE-ENTER, DOWN FROM .005
CONGRATS Your .0007 loading yesterday looks sweet today.
I'm retaining my share since selling it at this moment doesn't make sense. Besides, there's no benefit in engaging in arguments with these nonstop stupid nonsense, and irrational individuals.
In my previous post, I provided a clear explanation of the spin-off. That will be my final due diligence (DD) post for you. I won't be answering any more questions posted here or providing guidance here from this point on.
In my last post, I explained clearly the spin-off. That is my final DD post for you. No more questions and guidance answers on my end. If you have any questions, please send me a private message, and I'll address them through PM.